| Literature DB >> 36196076 |
Gengyu Han1,2,3, Siyu Zhou1,2,3, Wei Wang4, Wei Li1,2,3, Weipeng Qiu1,2,3, Xinhang Li1,2,3, Xiao Fan1,2,3, Weishi Li1,2,3.
Abstract
Background: Few study has investigated how paraspinal muscle endurance deteriorates in lumbar spinal stenosis (LSS) patients. In addition, little information is available on the relationship between clinical outcomes and the endurance of paraspinal muscles. Objective: To explore the correlation between paraspinal extensor muscle endurance, quality of life (QOL) and sagittal spinopelvic alignment. Besides, we attempted to propose a paraspinal extensor muscle endurance test (PEMET) classification for identifying the severity of clinical symptoms and sagittal imbalance in LSS patients.Entities:
Keywords: Classification system; Lumbar spinal stenosis; Paraspinal muscle endurance; Quality of life; Sagittal imbalance
Year: 2022 PMID: 36196076 PMCID: PMC9494036 DOI: 10.1016/j.jot.2022.08.005
Source DB: PubMed Journal: J Orthop Translat ISSN: 2214-031X Impact factor: 4.889
Figure 1The illustration of the endurance test for measuring paraspinal extensor muscle endurance.
Comparisons of clinical characteristics and endurance test between LSS and healthy controls.
| LSS (n = 171) | Control (n = 100) | p | |
|---|---|---|---|
| Age (years) | 63.29 ± 8.10 | 61.56 ± 6.1 | 0.094 |
| Sex (male/female) | 70/101 | 47/53 | 0.374 |
| BMI (kg/m2) | 25.48 ± 3.32 | 24.42 ± 2.8 | 0.012 |
| VAS-back | 4.85 ± 2.1 | 1.18 ± 1.77 | <0.001 |
| mFI-5 | 1.02 ± 1.08 | 0.39 ± 0.57 | <0.001 |
| Smoking | 17 | 14 | 0.328 |
| Duration of symptom (mo) | 89.25 ± 100.96 | — | |
| Number of stenotic levels | 2.11 ± 1.13 | — | |
| Endurance test (s) | 38.18 ± 37.24 | 134.23 ± 80.2 | <0.001 |
LSS, lumbar spinal stenosis; BMI, body mass index; VAS, visual analog scale; mFI-5, modified 5-item frailty index
The distribution of the performance time of endurance test in LSS patients and healthy controls.
| Percentile values | 10% | 20% | 25% | 30% | 40% | 50% | 60% | 70% | 75% | 80% |
|---|---|---|---|---|---|---|---|---|---|---|
| Test of LSS patients (s) | 0 | 0 | 10 | 17 | 24 | 31 | 38 | 50 | 56 | 60 |
| Test of healthy controls (s) | 43 | 62 | 71 | 79 | 85 | 112 | 147 | 174 | 184 | 206 |
LSS, lumbar spinal stenosis
From poor function to good function.
Correlations between the endurance test, symptoms and functional status and sagittal parameters in the LSS patients.
| VAS-back | VAS-leg | ODI | PT | SS | PI | LL | SVA | Cobb | |
|---|---|---|---|---|---|---|---|---|---|
| r | −0.46 | −0.192 | −0.357 | −0.164 | 0.065 | −0.069 | 0.212 | −0.308 | −0.141 |
| p | <0.001 | 0.012 | <0.001 | 0.038 | 0.413 | 0.388 | 0.007 | <0.001 | 0.076 |
VAS, visual analog scale; ODI, Oswestry Disability Index; PT, pelvic tilt; SS, sacral slope; PI, pelvic incidence; LL, lumbar lordosis; SVA, sagittal vertical axis
Multiple linear regression analysis of the relationship between the endurance test and clinical outcomes.
| Variable | β coefficient | Standardized β coefficient | P | |
|---|---|---|---|---|
| Model 1 | VAS-back | −8.631 (-11.15, −6.111) | −0.484 | <0.001 |
| Model 2 | VAS-leg | −1.614 (-4.372, 1.143) | −0.094 | 0.249 |
| Model 3 | ODI | −0.686 (-1.06, −0.312) | −0.285 | <0.001 |
| Model 4 | PT | −0.569 (-1.238, 0.1) | −0.142 | 0.095 |
| Model 5 | LL | 0.357 (-0.03, 0.744) | 0.153 | 0.07 |
| Model 6 | SVA | −0.252 (-0.39, −0.113) | −0.288 | <0.001 |
Age, BMI, duration of symptom, mFI-5, and the number of stenotic levels were included in each of the six models.
VAS, visual analog scale; ODI, Oswestry Disability Index; PT, pelvic tilt; LL, lumbar lordosis; SVA, sagittal vertical axis
Independent risk factors of poor functional status (ODI scores > 40) identified by logistic regression.
| Variable | Odds Ratio (95% CI) | P |
|---|---|---|
| Sex | 0.489 (0.231, 1.033) | 0.061 |
| Age | 1.044 (0.995, 1.096) | 0.076 |
| BMI | 0.923 (0.828, 1.029) | 0.151 |
| mFI-5 | 1.209 (0.843, 1.736) | 0.303 |
| Smoking | 1.327 (0.358, 4.921) | 0.673 |
| Duration of symptom | 0.997 (0.994, 1.001) | 0.163 |
| Number of stenotic levels | 1.058 (0.775, 1.443) | 0.724 |
| Endurance test | 0.985 (0.974, 0.996) | 0.006 |
BMI, body mass index; mFI-5, modified 5-item frailty index
Independent risk factors of sagittal imbalance (SVA > 50 mm) identified by logistic regression.
| Variable | Odds Ratio (95% CI) | P |
|---|---|---|
| Sex | 0.522 (0.236, 1.157) | 0.11 |
| Age | 1.034 (0.98, 1.091) | 0.227 |
| BMI | 1.207 (1.063, 1.372) | 0.004 |
| mFI-5 | 0.923 (0.636, 1.34) | 0.673 |
| Smoking | 2.666 (0.787, 9.031) | 0.115 |
| Duration of symptom | 1.001 (0.997, 1.005) | 0.661 |
| Number of stenotic levels | 0.825 (0.585, 1.165) | 0.275 |
| Endurance test | 0.981 (0.968, 0.995) | 0.007 |
BMI, body mass index; mFI-5, modified 5-item frailty index
Comparison of clinical characteristics, quality of life and sagittal parameters for the three LSS groups according to PEMET classification.
| Grade I (<10s) | Grade II (10–60s) | Grade III (≥60s) | P | |
|---|---|---|---|---|
| Number of participants | 41 | 93 | 37 | |
| Endurance test (s) | 0.88 ± 2.48 | 33.39 ± 13.35 | 91.57 ± 38.88 | <0.001 |
| Age (year) | 63.68 ± 8.58 | 62.57 ± 8.04 | 64.65 ± 7.8 | 0.396 |
| Sex (male/female) | 16/25 | 41/52 | 13/24 | 0.619 |
| BMI (kg/cm2) | 27 ± 3.5 | 25.3 ± 3.43 | 25.04 ± 3.16 | 0.194 |
| mFI-5 | 1 ± 0.87 | 1.16 ± 1.18 | 0.7 ± 0.97 | 0.09 |
| Smoking (yes) | 4 | 9 | 4 | 0.98 |
| Duration of symptom (mo) | 98.83 ± 91.55 | 87.8 ± 102.09 | 82.39 ± 109.72 | 0.758 |
| Number of stenotic levels | 2.31 ± 1.44 | 2.06 ± 0.97 | 2.03 ± 1.11 | 0.456 |
| VAS-back | 5.63 ± 2.05 | 4.6 ± 1.85 | 3.11 ± 2 | <0.001 |
| VAS-leg | 5.76 ± 1.67 | 4.81 ± 2.17 | 4.41 ± 2.37 | 0.013 |
| ODI | 57.22 ± 15.49 | 46.57 ± 14.07 | 40.81 ± 14.74 | <0.001 |
| ODI ≥40 (yes) | 36 (87.8%) | 55 (59.1%) | 17 (45.9%) | <0.001 |
| PT | 25.23 ± 10.51 | 22.27 ± 8.42 | 21.34 ± 9.77 | 0.15 |
| SS | 29.27 ± 11.42 | 30.92 ± 9.13 | 30.58 ± 10.05 | 0.682 |
| PI | 54.49 ± 13.56 | 53.19 ± 11.25 | 51.92 ± 14.01 | 0.68 |
| LL | 32.23 ± 16.31 | 40.69 ± 15.17 | 41.26 ± 14.27 | 0.01 |
| SVA | 51.69 ± 45.86 | 18.35 ± 37.67 | 17.55 ± 33.63 | <0.001 |
| SVA ≥50 mm (yes) | 21 (51.2%) | 22 (23.7%) | 6 (16.2%) | 0.001 |
LSS, lumbar spinal stenosis; BMI, body mass index; mFI-5, modified 5-item frailty index; VAS, visual analog scale; ODI, Oswestry Disability Index; PT, pelvic tilt; SS, sacral slope; PI, pelvic incidence; LL, lumbar lordosis; SVA, sagittal vertical axis
Post hoc tests of clinical outcomes between the three groups.
| Grade I and II | Grade I and III | Grade II and III | |
|---|---|---|---|
| Endurance test | <0.001 | <0.001 | <0.001 |
| VAS-back | 0.005 | <0.001 | <0.001 |
| VAS-leg | 0.018 | 0.005 | 0.33 |
| ODI | <0.001 | <0.001 | 0.043 |
| LL | 0.004 | 0.013 | 0.856 |
| SVA | <0.001 | <0.001 | 0.92 |
VAS, visual analog scale; ODI, Oswestry Disability Index; LL, lumbar lordosis; SVA, sagittal vertical axis
Figure 2The mean ODI and SVA for groups by increasing severity of the paraspinal muscle endurance.